A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial Summary This phase 1 clinical trial investigates the safety and immunogenicity of a peptide Read More
Tags :adults
Site Logo
Powered by AI
New Journal Citation Reports (JCR) 2025
All-Time Views
930K+ and Counting..!
Follow me on Linkedin for Latest Jobs and Scholarships
Join WhatsApp
Click the ICON to Join
Subscribe Youtube
Celebrating 6 Years
Now, it has been 6 years since it was launched in late July 2018 and is moving forward. Appreciate all the respected visitors! Please share this site with your friends to push science forward and improve human health.
Site Trust Score
Google Safe
